Answers are grounded in this paper and cite their sources.
Background: Previous studies have suggested that polymorphisms in and around the aldose reductase (AR) gene are associated with the development of diabetic microvascular disease. This study explored the hypothesis that the polymorphisms of the (A-C)n dinucleotide repeat sequence, located at 2.1 kilobase (kb) upstream of the transcription start site of AR gene, modulate the risk of diabetic neuropathy (DN).
No takes yet. Share an insight, caveat, or question.
Jeong et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: